MAPK1 and gastric cancer: Interestingly, similar with the observation by Hu et al [25], we noticed that kinase-dead, nuclear-localised ERK2 retained its inhibitory effect on Wnt5a transcription in both SGC-7901 and BGC-823 gastric cancer cells.